EU RESEARCH PROJECT MAPS GENES TO DEVELOP PERSONALISED MEDICINES
October 1st, 2010
BY KEITH NUTHALL
A EUROPEAN Union (EU) research project BLUEPRINT will spend Euro EUR40 million on examining the behaviour of blood genes in healthy people and leukaemia patients. Its consortium of 41 European universities, research centres and companies want to create 100 reference models of gene collections and environments, helping pharmaceutical companies tailor the development of medicines for different categories of patients. A BLUEPRINT note said the project would study the models "to advance and exploit knowledge of the underlying biological ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.